Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Objective:
To evaluate the safety and efficacy of topical cyclosporine eye drops (Restasis®) for the
treatment of epiphora caused by canalicular stenosis secondary to Docetaxel (Taxotere®)
treatment for various cancers.